Keyphrases
Neoadjuvant Chemotherapy
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Fanconi Anemia
100%
Gemcitabine
100%
Carboplatin
100%
Reduced Dose
100%
Tumor
33%
Bone Marrow Transplantation
33%
Neoadjuvant Therapy
33%
Older Men
16%
Malignancy
16%
Chemotherapy Regimen
16%
Antitumor Activity
16%
Tumor Size
16%
Squamous Cell Carcinoma (SqCC)
16%
DNA Crosslinking Agents
16%
Area under the Curve
16%
Treatment Toxicity
16%
Pulmonary Vein
16%
Right Lung
16%
Hematopoietic Reconstitution
16%
Pancytopenia
16%
Main Pulmonary Artery
16%
Bronchus Intermedius
16%
Whole-body Exposure
16%
Right Lower Lobectomy
16%
Right Pneumonectomy
16%
Right Middle Lobectomy
16%
2-cycles
16%
Congenital Malformations
16%
Medicine and Dentistry
Gemcitabine
100%
Carboplatin
100%
Neoadjuvant Chemotherapy
100%
Fanconi Anemia
100%
Non Small Cell Lung Cancer
100%
Neoplasm
50%
Bone Marrow Transplantation
33%
Neoadjuvant Therapy
33%
Low Drug Dose
16%
Cancer
16%
Non-Small Cell Lung Cancer
16%
Whole Body Radiation
16%
Squamous Cell Carcinoma
16%
Pulmonary Artery
16%
Congenital Malformation
16%
Side Effect
16%
Pulmonary Vein
16%
Antineoplastic Activity
16%
Lobectomy
16%
Pancytopenia
16%
DNA Cross Linking
16%
Pneumonectomy
16%
Chemotherapy Regimens
16%
Right Lung
16%
Isoprenaline
16%